Juvenile myoclonic epilepsy.
Juvenile myoclonic epilepsy is a genetically transferred generalized epilepsy that affects approximately 7% of adolescents and adults with epilepsy. Juvenile myoclonic epilepsy always has a myoclonic component alone or in combination with generalized tonic-clonic seizure or absence seizure. The myoclonic component is most prominent on waking or in a drowsy state. The electroencephalogram may be normal between seizures. Life-long treatment with valproate is effective in more than 80% of patients. The author describes the clinical features, diagnosis, and treatment of juvenile myoclonic epilepsy in a typical patient.
Kibria
E M
EM
College of Medicine, University of South Florida, Tampa.
D000328:Adult; D002220:Carbamazepine / Q000627:therapeutic use; D004569:Electroencephalography; D004831:Epilepsies, Myoclonic / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D014635:Valproic Acid / Q000627:therapeutic use*
D002220:Carbamazepine; D014635:Valproic Acid